CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma

BACKGROUND: Our previous studies have identified CA916798 as a chemotherapy resistance-associated gene in lung cancer. However, the histopathological relevance and biological function of CA916798 in lung adenocarcinoma (LUAD) remains to be delineated. In this study, we further investigated and explo...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jian, Lan, Xi, Liu, Xiayan, Deng, Caixia, Luo, Hu, Wang, Yan, Kang, Ping, Sun, Zhijian, Zhao, Lintao, Zhou, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035219/
https://www.ncbi.nlm.nih.gov/pubmed/36959566
http://dx.doi.org/10.1186/s12885-023-10735-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035219/
https://www.ncbi.nlm.nih.gov/pubmed/36959566
http://dx.doi.org/10.1186/s12885-023-10735-3

Ejemplares similares